$30,000 of GRAIL INC. lobbying was just disclosed, from Q4 of 2024, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Issues related to oncology and early multi-cancer detection, including diagnostics and screening; The Multi-Cancer Early Detection Screening Coverage Act. Issues related to oncology and early multi-cancer detection, including diagnostics and screening; The Multi-Cancer Early Detection Screening Coverage Act."
You can find more data on corporate lobbying on Quiver Quantitative.
GRAL Insider Trading Activity
GRAL insiders have traded $GRAL stock on the open market 8 times in the past 6 months. Of those trades, 4 have been purchases and 4 have been sales.
Here’s a breakdown of recent trading of $GRAL stock by insiders over the last 6 months:
- ROBERT P RAGUSA (Chief Executive Officer) sold 123,454 shares for an estimated $1,730,825
- JOSHUA J. OFMAN (President) sold 74,084 shares for an estimated $1,203,650
- CHUN R DING has made 4 purchases buying 78,829 shares for an estimated $1,024,698 and 0 sales.
- AARON FREIDIN (Chief Financial Officer) has made 0 purchases and 2 sales selling 46,093 shares for an estimated $681,057.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
